The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
NCT00797784 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2010-05-26
Summary
A 20 week study to assess the safety and efficacy of etanercept(Enbrel®)for the treatment of Discoid Lupus Erythematosus
Conditions
- Discoid Lupus Erythematosus (DLE)
Interventions
- DRUG
-
etanercept(Enbrel®)
etanercept(Enbrel®) 50mgs subcutaneous (SC) injections twice weekly for 20 weeks
Sponsors & Collaborators
-
Florida Academic Dermatology Centers
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)
NCT03556007 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
NCT00423098 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
NCT02547922 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Epratuzumab in Systemic Lupus Erythematosus
NCT00111306 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
NCT01261793 ·Status: COMPLETED ·Phase: PHASE3
-
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease
NCT01753401 ·Status: COMPLETED ·Phase: PHASE4
-
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
NCT00119678 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
NCT04433585 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
NCT04857034 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus
NCT05591222 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
NCT01294774 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus
NCT06261021 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus
NCT00752999 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase II Study of M2951 in SLE
NCT02975336 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
NCT02550652 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
NCT00383214 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
NCT06015737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
NCT06875960 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
NCT01262365 ·Status: COMPLETED ·Phase: PHASE3
-
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
NCT01777256 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants
NCT06625671 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
NCT02446912 ·Status: COMPLETED ·Phase: PHASE3
-
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
NCT06314282 ·Status: RECRUITING
-
Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
NCT02446899 ·Status: COMPLETED ·Phase: PHASE3